Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
KA Ramsay, RE Stockwell, SC Bell & TJ Kidd. (2016) Infection in cystic fibrosis: impact of the environment and climate. Expert Review of Respiratory Medicine 10:5, pages 505-519.
Read now
Read now
Articles from other publishers (16)
Halime Nayir Buyuksahin, Deniz Dogru, Nagehan Emiralioglu, Dilber Ademhan Tural, Beste Özsezen, Birce Sunman, Ismail Guzelkaş, Didem Alboğa, Sevtap Arikan‐Akdagli, Zeynep Sarıbaş, Dolunay Gulmez, Alpaslan Alp, Gülşen Hazırolan, Özge Soyer, Bülent Enis Şekerel, Gözde İnam, İlim Irmak, Ebru Damadoğlu, Fuat Kalyoncu, Ebru Yalçın, Ugur Ozcelik & Nural Kiper. (2023)
A case‐control study of the effects of
Aspergillus
clinical phenotypes on pulmonary functions in patients with cystic fibrosis
. Pediatric Pulmonology 58:4, pages 1185-1193.
Crossref
Crossref
Jenan Atiyah Ghafil & Ayaid Khadem Zgair. (2022) Bacterial secretions in growth medium stimulate the mouse respiratory innate immune response. Journal of Medical Microbiology 71:10.
Crossref
Crossref
Kim Verburg, Jacq van Neer, Margherita Duca & Hans de Cock. (2022) Novel Treatment Approach for Aspergilloses by Targeting Germination. Journal of Fungi 8:8, pages 758.
Crossref
Crossref
Valentina Fainardi, Chiara Sodini, Michela Deolmi, Andrea Ciuni, Kaltra Skenderaj, Maria Bice Stabile, Cosimo Neglia, Elena Mariotti Zani, Cinzia Spaggiari, Nicola Sverzellati, Susanna Esposito & Giovanna Pisi. (2022) Clinical Impact of Aspergillus fumigatus in Children with Cystic Fibrosis. Microorganisms 10:4, pages 739.
Crossref
Crossref
Claudia Lattanzi, Giulia Messina, Valentina Fainardi, Maria Candida Tripodi, Giovanna Pisi & Susanna Esposito. (2020) Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis: An Update on the Newest Diagnostic Tools and Therapeutic Approaches. Pathogens 9:9, pages 716.
Crossref
Crossref
M Boyle, J E Moore, J L Whitehouse, D Bilton & D G Downey. (2019) The diagnosis and management of respiratory tract fungal infection in cystic fibrosis: A UK survey of current practice. Medical Mycology 57:2, pages 155-160.
Crossref
Crossref
Hélène Guegan, Sylviane Chevrier, Chantal Belleguic, Eric Deneuville, Florence Robert-Gangneux & Jean-Pierre Gangneux. (2018) Performance of Molecular Approaches for Aspergillus Detection and Azole Resistance Surveillance in Cystic Fibrosis. Frontiers in Microbiology 9.
Crossref
Crossref
Mon Ohn, Paul Robinson, Hiran Selvadurai & Dominic A. Fitzgerald. (2017) Question 11: How should Allergic Bronchopulmonary Aspergillosis [ABPA] be managed in Cystic Fibrosis?. Paediatric Respiratory Reviews 24, pages 35-38.
Crossref
Crossref
Abigail C. Cowley, David J. Thornton, David W. Denning & Alexander Horsley. (2016) Aspergillosis and the role of mucins in cystic fibrosis. Pediatric Pulmonology 52:4, pages 548-555.
Crossref
Crossref
Silvia Moretti, Giorgia Renga, Vasilis Oikonomou, Claudia Galosi, Marilena Pariano, Rossana G. Iannitti, Monica Borghi, Matteo Puccetti, Marco De Zuani, Carlo E. Pucillo, Giuseppe Paolicelli, Teresa Zelante, Jean-Christophe Renauld, Oxana Bereshchenko, Paolo Sportoletti, Vincenzina Lucidi, Maria Chiara Russo, Carla Colombo, Ersilia Fiscarelli, Cornelia Lass-Flörl, Fabio Majo, Gabriella Ricciotti, Helmut Ellemunter, Luigi Ratclif, Vincenzo Nicola Talesa, Valerio Napolioni & Luigina Romani. (2017) A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis. Nature Communications 8:1.
Crossref
Crossref
Craig Williams, Ranjith Ranjendran & Gordon Ramage. (2016) Pathogenesis of Fungal Infections in Cystic Fibrosis. Current Fungal Infection Reports 10:4, pages 163-169.
Crossref
Crossref
Alexandre Alanio, Blandine Denis, Samia Hamane, Emmanuel Raffoux, Régis Peffault de la Tour, Sophie Touratier, Anne Bergeron & Stéphane Bretagne. (2016) New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?: Table 1.. Journal of Antimicrobial Chemotherapy 71:8, pages 2075-2078.
Crossref
Crossref
Rossana G. Iannitti, Valerio Napolioni, Vasilis Oikonomou, Antonella De Luca, Claudia Galosi, Marilena Pariano, Cristina Massi-Benedetti, Monica Borghi, Matteo Puccetti, Vincenzina Lucidi, Carla Colombo, Ersilia Fiscarelli, Cornelia Lass-Flörl, Fabio Majo, Lisa Cariani, Maria Russo, Luigi Porcaro, Gabriella Ricciotti, Helmut Ellemunter, Luigi Ratclif, Fernando Maria De Benedictis, Vincenzo Nicola Talesa, Charles A. Dinarello, Frank L. van de Veerdonk & Luigina Romani. (2016) IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. Nature Communications 7:1.
Crossref
Crossref
V. N. Maturu & R. Agarwal. (2015)
Prevalence of
Aspergillus
sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis
. Clinical & Experimental Allergy 45:12, pages 1765-1778.
Crossref
Crossref
Melanie Carevic, Anurag Singh, Nikolaus Rieber, Olaf Eickmeier, Matthias Griese, Andreas Hector & Dominik Hartl. (2015)
CXCR4
+
granulocytes reflect fungal cystic fibrosis lung disease
. European Respiratory Journal 46:2, pages 395-404.
Crossref
Crossref
Olaf Eickmeier, Andreas Hector, Anurag Singh, Sanjay H. Chotirmall & Dominik Hartl. (2014) Fungi in Cystic Fibrosis: Recent Findings and Unresolved Questions. Current Fungal Infection Reports 9:1, pages 1-5.
Crossref
Crossref